title: Non-Small Cell Lung Cancer Analysis Report 2025: Market Dominated by Roche, AstraZeneca, Merck, and Novartis, Fueled by Immuno-Oncology, Targeted Therapies, and Strategic Pipeline Collaborations
source: Yahoo
date: 2025-10-15
url: https://finnhub.io/api/news?id=d50bcbd6ac249c8ebcb4b6411344c21508850feb5b38fbad9309faf5868390c1
Opportunities in the NSCLC market include the adoption of targeted and immunotherapies such as PD-1/PD-L1 inhibitors, the potential in Asia Pacific driven by rising prevalence, and advancements in personalized treatments through biomarker-driven therapy. Growth is also supported by increasing R&D and healthcare investment.Dublin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The "Non-Small Cell Lung Cancer Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competi
